E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/3/2005 in the Prospect News Biotech Daily.

Medtronic maintained by Bear Stearns at market outperform

Medtronic Inc. was maintained by Bear Stearns analyst Rick Wise with a price target on the stock of $64 per share. Bear Stearns believes the upcoming Oct. 11 analyst day will provide a lift in share price. Despite possible questions raised about the five-year, 1,200-patient sport trial, which shows certain patients do not need spinal fusions, Bear Sterns said Medtronic's pipeline and emerging opportunities will continue to drive top-line growth. Medtronic shares Monday were down $0.39, or 0.73%, at $53.23 on volume of 4,752,900 shares versus the three-month running average of 3,421,680 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.